LPSN · As filed with the SEC
Liveperson balance sheet, by fiscal year
The statement as Liveperson presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 |
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | 95,004 | 183,237 | 210,782 | 391,781 |
| Restricted cash | — | 0 | 2,143 | — |
| Accounts receivable, net of allowances of $4,451 and $8,627 as of December 31, 2025 and 2024, respectively | 27,014 | 28,737 | 81,802 | 86,537 |
| Prepaid expenses and other current assets (Note 1) | 15,100 | 19,250 | 26,981 | 24,164 |
| Assets held for sale | — | — | 0 | 30,984 |
| Total current assets | 137,118 | 231,224 | 321,708 | 533,466 |
| Operating lease right-of-use assets (Note 9) | — | 48 | 4,135 | 1,604 |
| Property and equipment, net (Note 6) | 90,389 | 100,557 | 119,325 | 126,499 |
| Contract acquisition costs, net (Note 2) | 23,951 | 33,559 | 37,354 | 43,804 |
| Intangible assets, net (Note 5) | 13,409 | 15,070 | 61,625 | 78,103 |
| Goodwill, net (Note 5) | 184,902 | 222,554 | 285,631 | 296,214 |
| Deferred tax assets, net (Note 14) | 4,511 | 4,411 | 4,527 | 4,423 |
| Equity Method Investments | — | 0 | 0 | 2,264 |
| Other assets | 387 | 355 | 1,208 | 2,563 |
| Total assets | 454,667 | 607,778 | 835,513 | 1,088,940 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||
| Current liabilities: | ||||
| Accounts payable | 9,522 | 15,378 | 13,555 | 25,303 |
| Accrued expenses and other current liabilities (Note 7) | 38,700 | 66,530 | 97,024 | 131,440 |
| Deferred revenue (Note 2) | 54,295 | 57,980 | 81,858 | 84,494 |
| Current portion of long-term debt (Note 8) | 20,052 | 0 | 72,393 | — |
| Operating lease liabilities (Note 9) | — | 52 | 2,719 | 2,160 |
| Liabilities associated with assets held for sale | — | — | 0 | 10,357 |
| Total current liabilities | 122,569 | 139,940 | 267,549 | 253,754 |
| Deferred revenue, net of current portion (Note 2) | — | — | — | 174 |
| Senior notes, net of current portion (Note 8) | 371,732 | 527,070 | 511,565 | 737,423 |
| Operating lease liabilities, net of current portion (Note 9) | — | 0 | 2,173 | 682 |
| Deferred tax liabilities (Note 14) | 4,196 | 3,542 | 2,930 | 2,550 |
| Other liabilities | 665 | 4,542 | 3,158 | 26,269 |
| Total liabilities | 499,162 | 675,094 | 787,375 | 1,020,852 |
| Preferred stock, $0.001 par value - 5,000,000 shares authorized; none issued and outstanding as of both December 31, 2025 and 2024 | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value - 20,000,000 and 13,333,333 shares authorized; 12,223,729 and 6,263,782 shares issued, and 12,039,325 and 6,079,378 shares outstanding as of December 31, 2025 and 2024, respectively | 173 | 94 | 91 | 78 |
| Treasury stock, at cost; 184,404 shares as of December 31, 2025 and 2024 | (3) | (3) | (3) | (3) |
| Additional paid-in capital | 1,021,076 | 936,047 | 913,522 | 771,052 |
| Accumulated deficit | (1,058,494) | (991,261) | (856,988) | (692,362) |
| Accumulated other comprehensive loss | (7,247) | (12,193) | (8,484) | (10,677) |
| Total stockholders’ equity (deficit) | (44,495) | (67,316) | 48,138 | 68,088 |
| Total liabilities and stockholders’ equity (deficit) | 454,667 | 607,778 | 835,513 | 1,088,940 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.